1 Market Overview
1.1 Product Overview and Scope of Acute Intermittent Porphyria
1.2 Classification of Acute Intermittent Porphyria by Type
1.2.1 Overview: Global Acute Intermittent Porphyria Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Acute Intermittent Porphyria Revenue Market Share by Type in 2020
1.2.3 Gonadotropin-Releasing Hormone Analogues
1.2.4 Prophylactic Hematin Infusions
1.3 Global Acute Intermittent Porphyria Market by Application
1.3.1 Overview: Global Acute Intermittent Porphyria Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals & Clinics
1.3.3 Research Centers
1.4 Global Acute Intermittent Porphyria Market Size & Forecast
1.5 Global Acute Intermittent Porphyria Market Size and Forecast by Region
1.5.1 Global Acute Intermittent Porphyria Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Acute Intermittent Porphyria Market Size by Region, (2016-2021)
1.5.3 North America Acute Intermittent Porphyria Market Size and Prospect (2016-2026)
1.5.4 Europe Acute Intermittent Porphyria Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Acute Intermittent Porphyria Market Size and Prospect (2016-2026)
1.5.6 South America Acute Intermittent Porphyria Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Acute Intermittent Porphyria Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Acute Intermittent Porphyria Market Drivers
1.6.2 Acute Intermittent Porphyria Market Restraints
1.6.3 Acute Intermittent Porphyria Trends Analysis
2 Company Profiles
2.1 Dahaner
2.1.1 Dahaner Details
2.1.2 Dahaner Major Business
2.1.3 Dahaner Acute Intermittent Porphyria Product and Solutions
2.1.4 Dahaner Acute Intermittent Porphyria Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Dahaner Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Acute Intermittent Porphyria Product and Solutions
2.2.4 Roche Acute Intermittent Porphyria Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Roche Recent Developments and Future Plans
2.3 Bio-Rad Laboratories
2.3.1 Bio-Rad Laboratories Details
2.3.2 Bio-Rad Laboratories Major Business
2.3.3 Bio-Rad Laboratories Acute Intermittent Porphyria Product and Solutions
2.3.4 Bio-Rad Laboratories Acute Intermittent Porphyria Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.4 Siemens
2.4.1 Siemens Details
2.4.2 Siemens Major Business
2.4.3 Siemens Acute Intermittent Porphyria Product and Solutions
2.4.4 Siemens Acute Intermittent Porphyria Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Siemens Recent Developments and Future Plans
2.5 ARKRAY
2.5.1 ARKRAY Details
2.5.2 ARKRAY Major Business
2.5.3 ARKRAY Acute Intermittent Porphyria Product and Solutions
2.5.4 ARKRAY Acute Intermittent Porphyria Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 ARKRAY Recent Developments and Future Plans
2.6 Sysmex Corporation
2.6.1 Sysmex Corporation Details
2.6.2 Sysmex Corporation Major Business
2.6.3 Sysmex Corporation Acute Intermittent Porphyria Product and Solutions
2.6.4 Sysmex Corporation Acute Intermittent Porphyria Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Sysmex Corporation Recent Developments and Future Plans
2.7 ACON Laboratories
2.7.1 ACON Laboratories Details
2.7.2 ACON Laboratories Major Business
2.7.3 ACON Laboratories Acute Intermittent Porphyria Product and Solutions
2.7.4 ACON Laboratories Acute Intermittent Porphyria Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 ACON Laboratories Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Acute Intermittent Porphyria Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Acute Intermittent Porphyria Players Market Share
3.2.2 Top 10 Acute Intermittent Porphyria Players Market Share
3.2.3 Market Competition Trend
3.3 Acute Intermittent Porphyria Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Acute Intermittent Porphyria Revenue and Market Share by Type (2016-2021)
4.2 Global Acute Intermittent Porphyria Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Acute Intermittent Porphyria Revenue Market Share by Application (2016-2021)
5.2 Acute Intermittent Porphyria Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Acute Intermittent Porphyria Revenue by Type (2016-2026)
6.2 North America Acute Intermittent Porphyria Revenue by Application (2016-2026)
6.3 North America Acute Intermittent Porphyria Market Size by Country
6.3.1 North America Acute Intermittent Porphyria Revenue by Country (2016-2026)
6.3.2 United States Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
6.3.3 Canada Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
6.3.4 Mexico Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Acute Intermittent Porphyria Revenue by Type (2016-2026)
7.2 Europe Acute Intermittent Porphyria Revenue by Application (2016-2026)
7.3 Europe Acute Intermittent Porphyria Market Size by Country
7.3.1 Europe Acute Intermittent Porphyria Revenue by Country (2016-2026)
7.3.2 Germany Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
7.3.3 France Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
7.3.5 Russia Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
7.3.6 Italy Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Acute Intermittent Porphyria Revenue by Type (2016-2026)
8.2 Asia-Pacific Acute Intermittent Porphyria Revenue by Application (2016-2026)
8.3 Asia-Pacific Acute Intermittent Porphyria Market Size by Region
8.3.1 Asia-Pacific Acute Intermittent Porphyria Revenue by Region (2016-2026)
8.3.2 China Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
8.3.3 Japan Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
8.3.4 South Korea Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
8.3.5 India Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
8.3.7 Australia Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Acute Intermittent Porphyria Revenue by Type (2016-2026)
9.2 South America Acute Intermittent Porphyria Revenue by Application (2016-2026)
9.3 South America Acute Intermittent Porphyria Market Size by Country
9.3.1 South America Acute Intermittent Porphyria Revenue by Country (2016-2026)
9.3.2 Brazil Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
9.3.3 Argentina Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Acute Intermittent Porphyria Revenue by Type (2016-2026)
10.2 Middle East & Africa Acute Intermittent Porphyria Revenue by Application (2016-2026)
10.3 Middle East & Africa Acute Intermittent Porphyria Market Size by Country
10.3.1 Middle East & Africa Acute Intermittent Porphyria Revenue by Country (2016-2026)
10.3.2 Turkey Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
10.3.4 UAE Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Acute Intermittent Porphyria Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Acute Intermittent Porphyria Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Acute Intermittent Porphyria Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Acute Intermittent Porphyria Revenue (USD Million) by Region (2016-2021)
Table 5. Global Acute Intermittent Porphyria Revenue Market Share by Region (2021-2026)
Table 6. Dahaner Corporate Information, Head Office, and Major Competitors
Table 7. Dahaner Major Business
Table 8. Dahaner Acute Intermittent Porphyria Product and Solutions
Table 9. Dahaner Acute Intermittent Porphyria Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Roche Corporate Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Acute Intermittent Porphyria Product and Solutions
Table 13. Roche Acute Intermittent Porphyria Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 15. Bio-Rad Laboratories Major Business
Table 16. Bio-Rad Laboratories Acute Intermittent Porphyria Product and Solutions
Table 17. Bio-Rad Laboratories Acute Intermittent Porphyria Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Siemens Corporate Information, Head Office, and Major Competitors
Table 19. Siemens Major Business
Table 20. Siemens Acute Intermittent Porphyria Product and Solutions
Table 21. Siemens Acute Intermittent Porphyria Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. ARKRAY Corporate Information, Head Office, and Major Competitors
Table 23. ARKRAY Major Business
Table 24. ARKRAY Acute Intermittent Porphyria Product and Solutions
Table 25. ARKRAY Acute Intermittent Porphyria Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Sysmex Corporation Corporate Information, Head Office, and Major Competitors
Table 27. Sysmex Corporation Major Business
Table 28. Sysmex Corporation Acute Intermittent Porphyria Product and Solutions
Table 29. Sysmex Corporation Acute Intermittent Porphyria Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. ACON Laboratories Corporate Information, Head Office, and Major Competitors
Table 31. ACON Laboratories Major Business
Table 32. ACON Laboratories Acute Intermittent Porphyria Product and Solutions
Table 33. ACON Laboratories Acute Intermittent Porphyria Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Global Acute Intermittent Porphyria Revenue (USD Million) by Players (2019-2021)
Table 35. Global Acute Intermittent Porphyria Revenue Share by Players (2019-2021)
Table 36. Breakdown of Acute Intermittent Porphyria by Company Type (Tier 1, Tier 2 and Tier 3)
Table 37. Acute Intermittent Porphyria Players Head Office, Products and Services Provided
Table 38. Acute Intermittent Porphyria Mergers & Acquisitions in the Past Five Years
Table 39. Acute Intermittent Porphyria New Entrants and Expansion Plans
Table 40. Global Acute Intermittent Porphyria Revenue (USD Million) by Type (2016-2021)
Table 41. Global Acute Intermittent Porphyria Revenue Share by Type (2016-2021)
Table 42. Global Acute Intermittent Porphyria Revenue Forecast by Type (2021-2026)
Table 43. Global Acute Intermittent Porphyria Revenue by Application (2016-2021)
Table 44. Global Acute Intermittent Porphyria Revenue Forecast by Application (2021-2026)
Table 45. North America Acute Intermittent Porphyria Revenue by Type (2016-2021) & (USD Million)
Table 46. North America Acute Intermittent Porphyria Revenue by Type (2021-2026) & (USD Million)
Table 47. North America Acute Intermittent Porphyria Revenue by Application (2016-2021) & (USD Million)
Table 48. North America Acute Intermittent Porphyria Revenue by Application (2021-2026) & (USD Million)
Table 49. North America Acute Intermittent Porphyria Revenue by Country (2016-2021) & (USD Million)
Table 50. North America Acute Intermittent Porphyria Revenue by Country (2021-2026) & (USD Million)
Table 51. Europe Acute Intermittent Porphyria Revenue by Type (2016-2021) & (USD Million)
Table 52. Europe Acute Intermittent Porphyria Revenue by Type (2021-2026) & (USD Million)
Table 53. Europe Acute Intermittent Porphyria Revenue by Application (2016-2021) & (USD Million)
Table 54. Europe Acute Intermittent Porphyria Revenue by Application (2021-2026) & (USD Million)
Table 55. Europe Acute Intermittent Porphyria Revenue by Country (2016-2021) & (USD Million)
Table 56. Europe Acute Intermittent Porphyria Revenue by Country (2021-2026) & (USD Million)
Table 57. Asia-Pacific Acute Intermittent Porphyria Revenue by Type (2016-2021) & (USD Million)
Table 58. Asia-Pacific Acute Intermittent Porphyria Revenue by Type (2021-2026) & (USD Million)
Table 59. Asia-Pacific Acute Intermittent Porphyria Revenue by Application (2016-2021) & (USD Million)
Table 60. Asia-Pacific Acute Intermittent Porphyria Revenue by Application (2021-2026) & (USD Million)
Table 61. Asia-Pacific Acute Intermittent Porphyria Revenue by Region (2016-2021) & (USD Million)
Table 62. Asia-Pacific Acute Intermittent Porphyria Revenue by Region (2021-2026) & (USD Million)
Table 63. South America Acute Intermittent Porphyria Revenue by Type (2016-2021) & (USD Million)
Table 64. South America Acute Intermittent Porphyria Revenue by Type (2021-2026) & (USD Million)
Table 65. South America Acute Intermittent Porphyria Revenue by Application (2016-2021) & (USD Million)
Table 66. South America Acute Intermittent Porphyria Revenue by Application (2021-2026) & (USD Million)
Table 67. South America Acute Intermittent Porphyria Revenue by Country (2016-2021) & (USD Million)
Table 68. South America Acute Intermittent Porphyria Revenue by Country (2021-2026) & (USD Million)
Table 69. Middle East & Africa Acute Intermittent Porphyria Revenue by Type (2016-2021) & (USD Million)
Table 70. Middle East & Africa Acute Intermittent Porphyria Revenue by Type (2021-2026) & (USD Million)
Table 71. Middle East & Africa Acute Intermittent Porphyria Revenue by Application (2016-2021) & (USD Million)
Table 72. Middle East & Africa Acute Intermittent Porphyria Revenue by Application (2021-2026) & (USD Million)
Table 73. Middle East & Africa Acute Intermittent Porphyria Revenue by Country (2016-2021) & (USD Million)
Table 74. Middle East & Africa Acute Intermittent Porphyria Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Acute Intermittent Porphyria Picture
Figure 2. Global Acute Intermittent Porphyria Revenue Market Share by Type in 2020
Figure 3. Gonadotropin-Releasing Hormone Analogues
Figure 4. Prophylactic Hematin Infusions
Figure 5. Acute Intermittent Porphyria Revenue Market Share by Application in 2020
Figure 6. Hospitals & Clinics Picture
Figure 7. Research Centers Picture
Figure 8. Global Acute Intermittent Porphyria Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 9. Global Acute Intermittent Porphyria Revenue and Forecast (2016-2026) & (USD Million)
Figure 10. Global Acute Intermittent Porphyria Revenue Market Share by Region (2016-2026)
Figure 11. Global Acute Intermittent Porphyria Revenue Market Share by Region in 2020
Figure 12. North America Acute Intermittent Porphyria Revenue (USD Million) and Growth Rate (2016-2026)
Figure 13. Europe Acute Intermittent Porphyria Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Asia-Pacific Acute Intermittent Porphyria Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. South America Acute Intermittent Porphyria Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Acute Intermittent Porphyria Market Drivers
Figure 17. Acute Intermittent Porphyria Market Restraints
Figure 18. Acute Intermittent Porphyria Market Trends
Figure 19. Dahaner Recent Developments and Future Plans
Figure 20. Roche Recent Developments and Future Plans
Figure 21. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 22. Siemens Recent Developments and Future Plans
Figure 23. ARKRAY Recent Developments and Future Plans
Figure 24. Sysmex Corporation Recent Developments and Future Plans
Figure 25. ACON Laboratories Recent Developments and Future Plans
Figure 27. Global Acute Intermittent Porphyria Revenue Share by Players in 2020
Figure 28. Acute Intermittent Porphyria Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 29. Global Top 3 Players Acute Intermittent Porphyria Revenue Market Share in 2020
Figure 30. Global Top 10 Players Acute Intermittent Porphyria Revenue Market Share in 2020
Figure 31. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 32. Global Acute Intermittent Porphyria Revenue Share by Type in 2020
Figure 33. Global Acute Intermittent Porphyria Market Share Forecast by Type (2021-2026)
Figure 34. Global Acute Intermittent Porphyria Revenue Share by Application in 2020
Figure 35. Global Acute Intermittent Porphyria Market Share Forecast by Application (2021-2026)
Figure 36. North America Acute Intermittent Porphyria Sales Market Share by Type (2016-2026)
Figure 37. North America Acute Intermittent Porphyria Sales Market Share by Application (2016-2026)
Figure 38. North America Acute Intermittent Porphyria Revenue Market Share by Country (2016-2026)
Figure 39. United States Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Acute Intermittent Porphyria Sales Market Share by Type (2016-2026)
Figure 43. Europe Acute Intermittent Porphyria Sales Market Share by Application (2016-2026)
Figure 44. Europe Acute Intermittent Porphyria Revenue Market Share by Country (2016-2026)
Figure 45. Germany Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. France Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. United Kingdom Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Russia Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Italy Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Acute Intermittent Porphyria Sales Market Share by Type (2016-2026)
Figure 51. Asia-Pacific Acute Intermittent Porphyria Sales Market Share by Application (2016-2026)
Figure 52. Asia-Pacific Acute Intermittent Porphyria Revenue Market Share by Region (2016-2026)
Figure 53. China Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Japan Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. South Korea Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. India Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Southeast Asia Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Australia Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South America Acute Intermittent Porphyria Sales Market Share by Type (2016-2026)
Figure 60. South America Acute Intermittent Porphyria Sales Market Share by Application (2016-2026)
Figure 61. South America Acute Intermittent Porphyria Revenue Market Share by Country (2016-2026)
Figure 62. Brazil Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Argentina Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Middle East and Africa Acute Intermittent Porphyria Sales Market Share by Type (2016-2026)
Figure 65. Middle East and Africa Acute Intermittent Porphyria Sales Market Share by Application (2016-2026)
Figure 66. Middle East and Africa Acute Intermittent Porphyria Revenue Market Share by Country (2016-2026)
Figure 67. Turkey Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Saudi Arabia Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. UAE Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Methodology
Figure 71. Research Process and Data Source
【掲載企業】
Valeo、Continental、Magna International、Hitachi Automotive、Fujitsu、Ficosa